{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:57:30Z","timestamp":1790517450850,"version":"4.1.0"},"reference-count":88,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes & Infections"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/emi.2016.73","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T07:30:16Z","timestamp":1468999816000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":86,"title":["EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases"],"prefix":"10.1080","volume":"5","author":[{"given":"Qunying","family":"Mao","sequence":"first","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlian","family":"Bian","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglun","family":"Liang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"e_1_3_2_1_1","first-page":"757","author":"Fauquet CM","year":"2005","unstructured":"FauquetCM,MayoMA,ManiloffJet al.Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses.Elsevier Academic Press: San Diego.2005,757\u2013778.","journal-title":"Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses"},{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1111\/j.1469-0691.2012.03789.x","article-title":"Outbreak of hand, foot and mouth disease\/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study","volume":"18","author":"Mirand A","year":"2012","unstructured":"MirandA,HenquellC,ArchimbaudCet al.Outbreak of hand, foot and mouth disease\/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study.Clin Microbiol Infect2012; 18:E110\u2013E118.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao Q","year":"2014","unstructured":"MaoQ,WangY,YaoXet al.Coxsackievirus A16: epidemiology, diagnosis, and vaccine.Hum Vaccin Immunother2014; 10:360\u2013367.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","first-page":"19780","DOI":"10.3402\/ehtj.v6i0.19780","article-title":"Human enterovirus 71 epidemics: what\u2019s next?","volume":"6","author":"Yip CC","year":"2013","unstructured":"YipCC,LauSK,WooPCet al.Human enterovirus 71 epidemics: what\u2019s next?Emerg Health Threats J2013; 6:19780.","journal-title":"Emerg Health Threats J"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","first-page":"e52432","DOI":"10.1371\/journal.pone.0052432","article-title":"Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities","volume":"7","author":"Chen YJ","year":"2012","unstructured":"ChenYJ,ChangSC,TsaoKCet al.Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities.PLoS One2012; 7:e52432.","journal-title":"PLoS One"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid1802.111147","article-title":"Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011","volume":"18","author":"Fujimoto T","year":"2012","unstructured":"FujimotoT,IizukaS,EnomotoMet al.Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011.Emerg Infect Dis2012; 18:337\u2013339.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3201\/eid1904.121666","article-title":"Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012","volume":"19","author":"Puenpa J","year":"2013","unstructured":"PuenpaJ,ChieochansinT,LinsuwanonP.Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012.Emerg Infect Dis2013; 19:641\u2013643.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2014.04.001","article-title":"Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent","volume":"69","author":"Li JL","year":"2014","unstructured":"LiJL,YuanJ,YangFet al.Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent.J Infect2014; 69:299\u2013303.","journal-title":"J Infect"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jmv.24151","article-title":"Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10","volume":"87","author":"Yang Q","year":"2015","unstructured":"YangQ,DingJ,CaoJet al.Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10.J Med Virol2015; 87:954\u2013960.","journal-title":"J Med Virol"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcv.2012.04.021","article-title":"Epidemiological and aetiological characteristics of hand, foot and mouth disease in Ningbo, China, 2008-2011","volume":"54","author":"Ni H","year":"2012","unstructured":"NiH,YiB,YinJet al.Epidemiological and aetiological characteristics of hand, foot and mouth disease in Ningbo, China, 2008-2011.J Clin Virol2012; 54:342\u2013348.","journal-title":"J Clin Virol"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","first-page":"e84233","DOI":"10.1371\/journal.pone.0084233","article-title":"Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3","volume":"9","author":"Tian H","year":"2014","unstructured":"TianH,ZhangY,SunQet al.Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3.PLoS One2014; 9:e84233.","journal-title":"PLoS One"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14712590903379502","article-title":"Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines","volume":"10","author":"Kim DS","year":"2010","unstructured":"KimDS,NamJH.Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.Expert Opin Biol Ther2010; 10:179\u2013190.","journal-title":"Expert Opin Biol Ther"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1743-422X-9-38","article-title":"Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008","volume":"9","author":"Kim HJ","year":"2012","unstructured":"KimHJ,KangB,HwangSet al.Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008.Virol J2012; 9:38.","journal-title":"Virol J"},{"key":"e_1_3_2_14_1","unstructured":"China Food and Drug Administration CFDA PIZHUN CHANGDAO BINGDU 71XING MIEHUOYIMIAO SHENGCHAN SHANGSHI. Chinese .CFDA: Beijing.2015.Available athttp:\/\/www.sfda.gov.cn\/WS01\/CL0051\/136853.html (accessed on 27 January 2016)."},{"key":"e_1_3_2_15_1","unstructured":"China Food and Drug Administration CFDA PIZHUN SHANGSHIYAOPIN GONGGAO. Chinese .CFDA: Beijing.2016.Available athttp:\/\/www.sda.gov.cn\/WS01\/CL0087\/142000.html (accessed on 27 January 2016)."},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai Y","year":"2014","unstructured":"CaiY,KuZ,LiuQet al.A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.Vaccine2014; 32:2406\u20132412.","journal-title":"Vaccine"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku Z","year":"2014","unstructured":"KuZ,LiuQ,YeXet al.A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.Vaccine2014; 32:4296\u20134303.","journal-title":"Vaccine"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1586\/14787210.2015.1058156","article-title":"Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide","volume":"13","author":"Bian L","year":"2015","unstructured":"BianL,WangY,YaoXet al.Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide.Expert Rev Anti Infect Ther2015; 13:1061\u20131071.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007","volume":"28","author":"Ang LW","year":"2009","unstructured":"AngLW,KohBK,ChanKPet al.Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007.Ann Acad Med Singapore2009; 28:106\u2013112.","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1423-0127-21-16","article-title":"Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations","volume":"21","author":"Linsuwanon P","year":"2014","unstructured":"LinsuwanonP,PuenpaJ,HuangSWet al.Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations.J Biomed Sci2014; 21:16.","journal-title":"J Biomed Sci"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/rmv.1827","article-title":"Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014","volume":"25","author":"Liu SL","year":"2015","unstructured":"LiuSL,PanH,LiuPet al.Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014.Rev Med Virol2015; 25:115\u2013128.","journal-title":"Rev Med Virol"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot and mouth disease in China, 2008-12: an epidemiological study","volume":"14","author":"Xing W","year":"2014","unstructured":"XingW,LiaoQ,ViboudCet al.Hand, foot and mouth disease in China, 2008-12: an epidemiological study.Lancet Infect Dis2014; 14:308\u2013318.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_2_23_1","first-page":"615","article-title":"Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus","volume":"79","author":"Robinson CR","year":"1958","unstructured":"RobinsonCR,DoaneFW,RhodesAJ.Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus.Can Med Assoc J1958; 79:615\u2013621.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2105\/AJPH.81.12.1675","article-title":"Outbreak of coxsackievirus A16 hand, foot, and mouth disease in a child day-care center","volume":"81","author":"Ferson MJ","year":"1991","unstructured":"FersonMJ,BellSM.Outbreak of coxsackievirus A16 hand, foot, and mouth disease in a child day-care center.Am J Public Health1991; 81:1675\u20131676.","journal-title":"Am J Public Health"},{"key":"e_1_3_2_25_1","first-page":"R81","article-title":"Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales","volume":"6","author":"Bendig JW","year":"1996","unstructured":"BendigJW,FlemingDM.Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales.Commun Dis Rep CDR Rev1996; 6:R81\u2013R86.","journal-title":"Commun Dis Rep CDR Rev"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1875-9572(08)60023-6","article-title":"Enterovirus 71 in Taiwan","volume":"49","author":"Chang LY","year":"2008","unstructured":"ChangLY.Enterovirus 71 in Taiwan.Pediatr Neonatol2008; 49:103\u2013112.","journal-title":"Pediatr Neonatol"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3201\/eid1311.070632","article-title":"Epidemiologic and virologic investigation of hand, foot and mouth disease, Southern Vietnam, 2005","volume":"13","author":"Tu PV","year":"2007","unstructured":"TuPV,ThaoNTT,PereraDet al.Epidemiologic and virologic investigation of hand, foot and mouth disease, Southern Vietnam, 2005.Emerg Infect Dis2007; 13:1733\u20131741.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13312-013-0033-0","article-title":"An outbreak of hand, foot and mouth disease in Bhubaneswar, Odisha","volume":"50","author":"Kar BR","year":"2013","unstructured":"KarBR,DwibediB,KarSK.An outbreak of hand, foot and mouth disease in Bhubaneswar, Odisha.Indian Pediatr2013; 50:139\u2013142.","journal-title":"Indian Pediatr"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang CY","year":"2004","unstructured":"WangCY,Li LuF,WuMHet al.Fatal coxsackievirus A16 infection.Pediatr Infect Dis J2004; 23:275\u2013276.","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2010.07.006","article-title":"The largest outbreak of hand, foot and mouth disease in Singapore in 2008: the role of enterovirus71 and coxsackievirus A strains","volume":"14","author":"Wu Y","year":"2010","unstructured":"WuY,YeoA,PhoonMCet al.The largest outbreak of hand, foot and mouth disease in Singapore in 2008: the role of enterovirus71 and coxsackievirus A strains.Int J Infect Dis2010; 14:e1076.","journal-title":"Int J Infect Dis"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3201\/eid1904.121589","article-title":"Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011","volume":"19","author":"Montes M","year":"2013","unstructured":"MontesM,ArtiedaJ,Pi\u00f1eiroLDet al.Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011.Emerg Infect Dis2013; 19:676\u2013678.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","first-page":"e98888","DOI":"10.1371\/journal.pone.0098888","article-title":"Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012","volume":"9","author":"Puenpa J","year":"2014","unstructured":"PuenpaJ,MauleekoonphairojJ,LinsuwanonPet al.Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012.PLoS One2014; 9:e98888.","journal-title":"PLoS One"},{"key":"e_1_3_2_33_1","unstructured":"Centers for Disease Control and Prevention (CDC).Notes from the field: severe hand foot and mouth disease associated with coxsackievirus A6\u2013Alabama Connecticut California and Nevada November 2011-February 2012. MMWR Morb Mortal Wkly Rep 2012; 61 :213\u2013214."},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","first-page":"20745","DOI":"10.2807\/1560-7917.ES2014.19.12.20745","article-title":"Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014","volume":"19","author":"Sinclair C","year":"2014","unstructured":"SinclairC,GauntE,SimmondsPet al.Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014.Euro Surveill2014; 19:20745.","journal-title":"Euro Surveill"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.7.4.14422","article-title":"Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy","volume":"7","author":"Kim DS","year":"2011","unstructured":"KimDS,NamJH.Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy.Hum Vaccin2011; 7:410\u2013416.","journal-title":"Hum Vaccin"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4014\/jmb.0810.584","article-title":"Molecular and epidemiological characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006","volume":"19","author":"Baek K","year":"2009","unstructured":"BaekK,ParkK,JungEet al.Molecular and epidemiological characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006.J Microbiol Biotechnol2009; 19:1055\u20131064.","journal-title":"J Microbiol Biotechnol"},{"key":"e_1_3_2_37_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1743-422X-8-297","article-title":"Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009","volume":"8","author":"Baek K","year":"2011","unstructured":"BaekK,YeoS,LeeBet al.Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009.Virol J2011; 8:297.","journal-title":"Virol J"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.47102\/annals-acadmedsg.V32N3p381","article-title":"Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore","volume":"32","author":"Shah VA","year":"2003","unstructured":"ShahVA,ChongCY,ChanKPet al.Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore.Ann Acad Med Singapore2003; 32:381\u2013387.","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_3_2_39_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jmii.2011.01.029","article-title":"Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008","volume":"44","author":"Hsu CH","year":"2011","unstructured":"HsuCH,LuCY,ShaoPLet al.Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008.J Microbiol Immunol Infect2011; 44:265\u2013273.","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/jmv.24275","article-title":"Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013","volume":"87","author":"Yao X","year":"2015","unstructured":"YaoX,BianLL,LuWWet al.Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.J Med Virol2015; 87:2009\u20132017.","journal-title":"J Med Virol"},{"key":"e_1_3_2_41_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jmv.23478","article-title":"A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009","volume":"85","author":"Chen P","year":"2013","unstructured":"ChenP,TaoZ,SongYet al.A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009.J Med Virol2013; 85:483\u2013489.","journal-title":"J Med Virol"},{"key":"e_1_3_2_42_1","first-page":"515","article-title":"Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79","volume":"99","author":"Moore M","year":"1984","unstructured":"MooreM,KaplanMH,McPheeJet al.Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79.Public Health Rep1984; 99:515\u2013522.","journal-title":"Public Health Rep"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/tropej\/fmt086","article-title":"A case of myocarditis following neonatal meningitis caused by coxsackievirus B1 in spite of intravenous immunoglobulin treatment","volume":"60","author":"Bae EY","year":"2014","unstructured":"BaeEY,LeeEJ,HanSBet al.A case of myocarditis following neonatal meningitis caused by coxsackievirus B1 in spite of intravenous immunoglobulin treatment.J Trop Pediatr2014; 60:164\u2013167.","journal-title":"J Trop Pediatr"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.meegid.2012.10.016","article-title":"Picornavirus and enterovirus diversity with associated human diseases","volume":"14","author":"Tapparel C","year":"2013","unstructured":"TapparelC,SiegristF,PettyTJet al.Picornavirus and enterovirus diversity with associated human diseases.Infect Genet Evol2013; 14:282\u2013293.","journal-title":"Infect Genet Evol"},{"key":"e_1_3_2_45_1","first-page":"367","article-title":"Genetic analysis of Echovirus 30 isolated from hand-foot-mouth disease causes and healthy controls from Shandong, China in 2010","volume":"3","author":"Pei YW","year":"2013","unstructured":"PeiYW,WangJX,LinYet al.Genetic analysis of Echovirus 30 isolated from hand-foot-mouth disease causes and healthy controls from Shandong, China in 2010.Chin J Viral Dis2013; 3:367\u2013371.","journal-title":"Chin J Viral Dis"},{"key":"e_1_3_2_46_1","doi-asserted-by":"crossref","first-page":"e67157","DOI":"10.1371\/journal.pone.0067157","article-title":"Epidemics and frequent recombination within species in outbreaks of human enterovirus B-associated hand,foot and mouth disease in Shandong China in 2010 and 2011","volume":"8","author":"Zhang T","year":"2013","unstructured":"ZhangT,DuJ,XueYet al.Epidemics and frequent recombination within species in outbreaks of human enterovirus B-associated hand,foot and mouth disease in Shandong China in 2010 and 2011.PLoS One2013; 8:e67157.","journal-title":"PLoS One"},{"key":"e_1_3_2_47_1","first-page":"613","article-title":"Spectrum analysis of hand, foot and mouth disease in Guangzhou in 2011","volume":"12","author":"He P","year":"2012","unstructured":"HeP,ChenC,DiBet al.Spectrum analysis of hand, foot and mouth disease in Guangzhou in 2011.J Trop Med2012; 12:613\u2013616.","journal-title":"J Trop Med"},{"key":"e_1_3_2_48_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00705-012-1476-7","article-title":"Molecular identification of enteroviruses associated with aseptic meningitis in children from India","volume":"158","author":"Kumar A","year":"2013","unstructured":"KumarA,ShuklaD,KumarRet al.Molecular identification of enteroviruses associated with aseptic meningitis in children from India.Arch Virol2013; 158:211\u2013215.","journal-title":"Arch Virol"},{"key":"e_1_3_2_49_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/01.RES.74.2.182","article-title":"Viral infection and the pathogenesis of dilated cardiomyopathy","volume":"74","author":"Martino TA","year":"1994","unstructured":"MartinoTA,LiuP,SoleMJ.Viral infection and the pathogenesis of dilated cardiomyopathy.Circ Res1994; 74:182\u2013188.","journal-title":"Circ Res"},{"key":"e_1_3_2_50_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcla.20129","article-title":"Enterovirus meningitis in Greece from 2003-2005: diagnosis, CSF laboratory findings, and clinical manifestations","volume":"20","author":"Dumaidi K","year":"2006","unstructured":"DumaidiK,FrantzidouF,PapaAet al.Enterovirus meningitis in Greece from 2003-2005: diagnosis, CSF laboratory findings, and clinical manifestations.J Clin Lab Anal2006; 20:177\u2013183.","journal-title":"J Clin Lab Anal"},{"key":"e_1_3_2_51_1","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu FC","year":"2013","unstructured":"ZhuFC,MengFY,LiJXet al.Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet2013; 381:2024\u20132032.","journal-title":"Lancet"},{"key":"e_1_3_2_52_1","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.vaccine.2013.03.015","article-title":"A phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine","volume":"31","author":"Cheng A","year":"2013","unstructured":"ChengA,FungCP,LiuCCet al.A phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.Vaccine2013; 31:2471\u20132476.","journal-title":"Vaccine"},{"key":"e_1_3_2_53_1","unstructured":"National Institutes of Health Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand Foot and Mouth Disease Caused by Enterovirus 71. ClinicalTrials.gov Identifier: NCT01376479 .NIH: USA.2015.Available athttps:\/\/prsinfo.clinicaltrial.gov\/ct2\/show\/nct01376479?term=inviragen\u00b1%28singapore%29\u00b1pte\u00b1ltd.&rank=1%202013 (accessed 27 January 27 2016)."},{"key":"e_1_3_2_54_1","doi-asserted-by":"crossref","first-page":"e0136420","DOI":"10.1371\/journal.pone.0136420","article-title":"Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse","volume":"10","author":"Wu CY","year":"2015","unstructured":"WuCY,LinYW,KuoCHet al.Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse.PLoS One2015; 10:e0136420.","journal-title":"PLoS One"},{"key":"e_1_3_2_55_1","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1128\/JVI.02856-06","article-title":"An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys","volume":"81","author":"Arita M","year":"2007","unstructured":"AritaM,NagataN,IwataNet al.An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.J. Virol2007; 81:9386\u20139395.","journal-title":"J. Virol"},{"key":"e_1_3_2_56_1","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung YC","year":"2008","unstructured":"ChungYC,HoMS,WuJCet al.Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.Vaccine2008; 26:1855\u20131862.","journal-title":"Vaccine"},{"key":"e_1_3_2_57_1","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku Z","year":"2013","unstructured":"KuZ,YeX,HuangXet al.Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.PLoS One2013; 8:e57601.","journal-title":"PLoS One"},{"key":"e_1_3_2_58_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2014.02.015","article-title":"A murine model of coxsackievirus A16 infection for anti-viral evaluation","volume":"105","author":"Liu Q","year":"2014","unstructured":"LiuQ,ShiJ,HuangXet al.A murine model of coxsackievirus A16 infection for anti-viral evaluation.Antiviral Res2014; 105:26\u201331.","journal-title":"Antiviral Res"},{"key":"e_1_3_2_59_1","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/v7072803","article-title":"Optimization and characterization of candidate strain for coxsackievirus A16 inactivated vaccine","volume":"7","author":"Li J","year":"2015","unstructured":"LiJ,LiuG,LiuXet al.Optimization and characterization of candidate strain for coxsackievirus A16 inactivated vaccine.Viruses2015; 7:3891\u20133909.","journal-title":"Viruses"},{"key":"e_1_3_2_60_1","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi J","year":"2013","unstructured":"ShiJ,HuangX,LiuQet al.Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16.Vaccine2013; 31:2130\u20132136.","journal-title":"Vaccine"},{"key":"e_1_3_2_61_1","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1007\/s00253-013-5257-3","article-title":"Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against coxsackievirus A16 in mice","volume":"97","author":"Zhao H","year":"2013","unstructured":"ZhaoH,LiHY,HanJFet al.Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against coxsackievirus A16 in mice.Appl Microbiol Biotechnol2013; 97:10445\u201310452.","journal-title":"Appl Microbiol Biotechnol"},{"key":"e_1_3_2_62_1","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong M","year":"2014","unstructured":"GongM,ZhuH,ZhouJet al.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.J Virol2014; 88:6444\u20136452.","journal-title":"J Virol"},{"key":"e_1_3_2_63_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymeth.2015.09.023","article-title":"Characterizing enterovirus 71 and coxsackievirus A16 virus-like particles production in insect cells","volume":"95","author":"Somasundaram B","year":"2016","unstructured":"SomasundaramB,ChangC,FanYYet al.Characterizing enterovirus 71 and coxsackievirus A16 virus-like particles production in insect cells.Methods2016; 95:38\u201345.","journal-title":"Methods"},{"key":"e_1_3_2_64_1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4161\/hv.28397","article-title":"Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinicaltrial","volume":"10","author":"Chen YJ","year":"2014","unstructured":"ChenYJ,MengFY,MaoQet al.Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinicaltrial.Hum Vaccin Immunother2014; 10:1366\u20131372.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_65_1","first-page":"129","article-title":"Two-year efficacy and immunogenicity of Sinovac enterovirus 71 vaccine against hand, foot and mouth disease in children","volume":"15","author":"Li JX","year":"2015","unstructured":"LiJX,SongYF,WangLet al.Two-year efficacy and immunogenicity of Sinovac enterovirus 71 vaccine against hand, foot and mouth disease in children.Expert Rev Vaccines2015; 15:129\u2013137.","journal-title":"Expert Rev Vaccines"},{"key":"e_1_3_2_66_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12916-015-0448-7","article-title":"Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations","volume":"13","author":"Liu L","year":"2015","unstructured":"LiuL,MoZ,LiangZet al.Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.BMC Med2015; 13:226.","journal-title":"BMC Med"},{"key":"e_1_3_2_67_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(12)61764-4","article-title":"Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"381","author":"Zhu FC","year":"2013","unstructured":"ZhuFC,LiangZL,LiXLet al.Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.Lancet2013; 381:1037\u20131045.","journal-title":"Lancet"},{"key":"e_1_3_2_68_1","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1080\/21645515.2015.1011975","article-title":"The compatibility of inactivated-enterovirus 71 vaccination with coxsackievirus A16 and Poliovirus immunizations in humans and animals","volume":"11","author":"Mao Q","year":"2015","unstructured":"MaoQ,WangY,ShaoJet al.The compatibility of inactivated-enterovirus 71 vaccination with coxsackievirus A16 and Poliovirus immunizations in humans and animals.Hum Vaccin Immunother2015; 11:2723\u20132733.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_69_1","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.1016\/j.vaccine.2011.10.018","article-title":"Establishing China\u2019s national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines","volume":"29","author":"Liang Z","year":"2011","unstructured":"LiangZ,MaoQ,GaoQet al.Establishing China\u2019s national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.Vaccine2011; 29:9668\u20139674.","journal-title":"Vaccine"},{"key":"e_1_3_2_70_1","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/cti.2014.24","article-title":"EV71 vaccine, an invaluable gift for children","volume":"3","author":"Liang Z","year":"2014","unstructured":"LiangZ,WangJ.EV71 vaccine, an invaluable gift for children.Clin Transl Immunology2014; 3:e28.","journal-title":"Clin Transl Immunology"},{"key":"e_1_3_2_71_1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai Y","year":"2013","unstructured":"CaiY,LiuQ,HuangXet al.Active immunization with a coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.Vaccine2013; 31:2215\u20132221.","journal-title":"Vaccine"},{"key":"e_1_3_2_72_1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4161\/hv.27295","article-title":"The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems","volume":"10","author":"Qi An W","year":"2014","unstructured":"Qi AnW,Guo SuZ,Wen PanRet al.The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.Hum Vaccin Immunother2014; 10:628\u2013639.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_73_1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/hv.28083","article-title":"Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line","volume":"10","author":"Yang E","year":"2014","unstructured":"YangE,ChengC,ZhangYet al.Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line.Hum Vaccin Immunother2014; 10:1266\u20131273.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_74_1","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4161\/hv.29823","article-title":"Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus A16 infection in newborn mice","volume":"10","author":"Sun S","year":"2014","unstructured":"SunS,JiangL,LiangZet al.Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus A16 infection in newborn mice.Hum Vaccin Immunother2014; 10:2885\u20132895.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_75_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.micinf.2014.11.004","article-title":"Towards broadly protective polyvalent vaccines against hand, foot and mouth disease","volume":"17","author":"Liu Q","year":"2015","unstructured":"LiuQ,TongX,HuangZ.Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.Microbes Infect2015; 17:155\u2013162.","journal-title":"Microbes Infect"},{"key":"e_1_3_2_76_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3181\/00379727-216-44155","article-title":"Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine","volume":"216","author":"See DM","year":"1997","unstructured":"SeeDM,TillesJG.Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine.Proc Soc Exp Biol Med1997; 216:52\u201356.","journal-title":"Proc Soc Exp Biol Med"},{"key":"e_1_3_2_77_1","first-page":"480","article-title":"A bivalent VP1 gene vaccine against Coxsackie virus B1\/B3","volume":"81","author":"Wu XY","year":"2001","unstructured":"WuXY,ZhaoTQ,TianYet al.A bivalent VP1 gene vaccine against Coxsackie virus B1\/B3.Natl Med J China2001; 81:480\u2013484.","journal-title":"Natl Med J China"},{"key":"e_1_3_2_78_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/viro.1999.0048","article-title":"Structural and functional analysis of the 5\u2032 untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants","volume":"265","author":"Liu Z","year":"1999","unstructured":"LiuZ,CarthyCM,CheungPet al.Structural and functional analysis of the 5\u2032 untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants.Virology1999; 265:206\u2013217.","journal-title":"Virology"},{"key":"e_1_3_2_79_1","first-page":"147","article-title":"Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation","volume":"14","author":"M\u2019hadheb-Gharbi MB","year":"2008","unstructured":"M\u2019hadheb-GharbiMB,El HiarR,PaulousSet al.Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation.J Mol Microbiol Biotechnol2008; 14:147\u2013156.","journal-title":"J Mol Microbiol Biotechnol"},{"key":"e_1_3_2_80_1","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2011.07.049","article-title":"Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination","volume":"29","author":"Lan J","year":"2011","unstructured":"LanJ,GaoZ,XiongHet al.Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.Vaccine2011; 29:6894\u20136902.","journal-title":"Vaccine"},{"key":"e_1_3_2_81_1","unstructured":"Economic Daily. EV71 SHOUZUKOU YIMIAO KAISHI JIEZHONG MEIJI JIAGE BU CHAO 218 YUAN . Chinese. Beijing: ED 2016. Available athttp:\/\/baby.ce.cn\/qt\/201603\/29\/t20160329_3652260.shtml (accessed on 13 April 2016)."},{"key":"e_1_3_2_82_1","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1080\/21645515.2015.1059980","article-title":"Disease burden of enterovirus 71 in rural central China: a community-based survey","volume":"11","author":"Gan ZK","year":"2015","unstructured":"GanZK,JinH,LiJXet al.Disease burden of enterovirus 71 in rural central China: a community-based survey.Hum Vaccin Immunother2015; 11:2400\u20132405.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_83_1","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1016\/j.vaccine.2010.09.065","article-title":"Forecasting the economic value of an enterovirus 71 (EV71) vaccine","volume":"28","author":"Lee BY","year":"2010","unstructured":"LeeBY,WateskaAR,BaileyRRet al.Forecasting the economic value of an enterovirus 71 (EV71) vaccine.Vaccine2010; 28:7731\u20137736.","journal-title":"Vaccine"},{"key":"e_1_3_2_84_1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.vaccine.2014.10.081","article-title":"Considerations for developing an immunization strategy with enterovirus 71 vaccine","volume":"33","author":"Li L","year":"2015","unstructured":"LiL,YinH,AnZet al.Considerations for developing an immunization strategy with enterovirus 71 vaccine.Vaccine2015; 33:1107\u20131112.","journal-title":"Vaccine"},{"key":"e_1_3_2_85_1","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/21645515.2015.1049780","article-title":"Is a multivalent hand, foot, and mouth disease vaccine feasible?","volume":"11","author":"Klein M","year":"2015","unstructured":"KleinM,ChongP.Is a multivalent hand, foot, and mouth disease vaccine feasible?Hum Vaccin Immunother2015; 11:2688\u20132704.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_86_1","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2014.08.064","article-title":"Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases","volume":"32","author":"Liu CC","year":"2014","unstructured":"LiuCC,ChowYH,ChongPet al.Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.Vaccine2014; 32:6177\u20136182.","journal-title":"Vaccine"},{"key":"e_1_3_2_87_1","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.3390\/v7112916","article-title":"Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice","volume":"7","author":"Caine EA","year":"2015","unstructured":"CaineEA,FuchsJ,DasSCet al.Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice.Viruses2015; 7:5919\u20135932.","journal-title":"Viruses"},{"key":"e_1_3_2_88_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"Liu CC","year":"2016","unstructured":"LiuCC,GuoMS,WuSRet al.Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.Antiviral Res2016; 129:58\u201366.","journal-title":"Antiviral Res"}],"container-title":["Emerging Microbes & Infections"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emi201673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emi201673","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1038\/emi.2016.73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/emi201673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T09:29:38Z","timestamp":1718702978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1038\/emi.2016.73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1038\/emi.2016.73"],"URL":"https:\/\/doi.org\/10.1038\/emi.2016.73","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}